Unknown

Dataset Information

0

Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.


ABSTRACT: The 22q11.2 deletion syndrome (22q11.2DS) is a neurodevelopmental disorder associated with a number of volumetric brain abnormalities. The syndrome is also associated with an increased risk for neuropsychiatric disorders including schizophrenia and autism spectrum disorder. An earlier meta-analysis showed reduced grey and white matter volumes in individuals with 22q11.2DS. Since this analysis was conducted, the number of studies has increased markedly, permitting more precise estimates of effects and more regions to be examined. Although 22q11.2DS is clinically heterogeneous, it is not known to what extent this heterogeneity is mirrored in neuroanatomy. The aim of this study was thus to investigate differences in mean brain volume and structural variability within regions, between 22q11.2DS and typically developing controls. We examined studies that reported measures of brain volume using MRI in PubMed, Web of Science, Scopus and PsycINFO from inception to 1 May 2019. Data were extracted from studies in order to calculate effect sizes representing case-control difference in mean volume, and in the variability of volume (as measured using the log variability ratio (lnVR) and coefficient of variation ratio (CVR)). We found significant overall decreases in mean volume in 22q11.2DS compared with control for: total brain (g?=?-0.96; p?

SUBMITTER: Rogdaki M 

PROVIDER: S-EPMC7387301 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Magnitude and heterogeneity of brain structural abnormalities in 22q11.2 deletion syndrome: a meta-analysis.

Rogdaki Maria M   Gudbrandsen Maria M   McCutcheon Robert A RA   Blackmore Charlotte E CE   Brugger Stefan S   Ecker Christine C   Craig Michael C MC   Daly Eileen E   Murphy Declan G M DGM   Howes Oliver O  

Molecular psychiatry 20200110 8


The 22q11.2 deletion syndrome (22q11.2DS) is a neurodevelopmental disorder associated with a number of volumetric brain abnormalities. The syndrome is also associated with an increased risk for neuropsychiatric disorders including schizophrenia and autism spectrum disorder. An earlier meta-analysis showed reduced grey and white matter volumes in individuals with 22q11.2DS. Since this analysis was conducted, the number of studies has increased markedly, permitting more precise estimates of effect  ...[more]

Similar Datasets

| S-EPMC10785196 | biostudies-literature
| S-EPMC3129332 | biostudies-other
| S-EPMC7825015 | biostudies-literature
| S-EPMC6688301 | biostudies-literature
| S-EPMC10998724 | biostudies-literature
| S-EPMC4996003 | biostudies-literature
| S-EPMC7391171 | biostudies-literature
| S-EPMC6214629 | biostudies-literature
| S-EPMC5363275 | biostudies-literature
| S-EPMC6335527 | biostudies-literature